Clinical audit of patients using DPP4 inhibitors in longstanding type 2 diabetes

• Published in: Diabetes & metabolic syndrome clinical research & reviews Vol. 9; no. 4; pp. 277 - 279
• Main Authors: Kumar, K.V.S. Hari, Gupta, A.K
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.10.2015
• Subjects: Aged; Biomarkers - metabolism; Blood Glucose - metabolism; Clinical Audit; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - metabolism; Dipeptidyl-Peptidase IV Inhibitors - therapeutic use; DPP4 inhibitors; Endocrinology & Metabolism; Female; Follow-Up Studies; Gliptins; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Type 2 diabetes; Type 2 diabetes; Clinical audit; DPP4 inhibitors; Gliptins

Abstract Aims Dipeptidyl peptidase-4 inhibitors (DPP 4i) are oral hypoglycemic agents and are supposed to be beneficial in the early stages of diabetes. In this study, we evaluated the role of DPP4i in long standing type 2 diabetes mellitus (T2DM). Materials and methods This retrospective data analy...